OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
Clinical trial NCT05972954 · COMPLETED
Trial details
- NCT number
- NCT05972954
- Sponsor
- Omeicos Therapeutics GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-22
- Primary completion
- 2025-05-14
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.